On March 10 and 11, 2020, before social-distancing measures were put in place due to the COVID-19 pandemic, a conference of more than 200 medical professionals from across the United States gathered at the Union League of Philadelphia for the Sixth Annual Children’s Hospital of Philadelphia (CHOP) Chronic Lung Disease Conference.
Read morePublished on in Neonatology Update
A patient was able to be weaned off mechanical ventilation for the first time of his life just 16 days after a lobectomy at Children's Hospital of Philadelphia.
Published on in CHOP News
On March 13, more than 300 medical professionals from across the United States and Sweden gathered for the Fifth Annual Chronic Lung Disease Conference. This year marked the largest conference to date.
Published on in Neonatology Update
This case study illustrates how infants with severe chronic lung disease can make great improvements with multidisciplinary, individualized care.
Published on in CHOP News
For extremely preterm infants requiring resuscitation at birth, a ventilation strategy involving two sustained inflations, compared with standard intermittent positive pressure ventilation, did not reduce the risk of BPD or death at 36 weeks postmenstrual age.
Published on in Neonatology Update
Dr. Zhang, MD, recently received the Alan R. Cohen Master Clinician Award to recognize her extraordinary talents and contributions to patient care.
Published on in Neonatology Update
Dr. Gibbs has been appointed as Medical Director of the Newborn and Infant Chronic Lung Disease (NeoCLD) Program, where she will lead our multidisciplinary team as we continue to make a difference for children with CLD.
Published on in CHOP News
Born at 23 weeks with little hope of survival, Micha was transferred to CHOP, where with the help of his medical team and his parents’ determination, he is thriving.
Published on in Children's Doctor
We discuss the case of a 10-month-old male infant who presented to CHOP ED with respiratory complications due to chronic lung disease.
Published on in Children's View
Three Frontier Programs (NeoCLD Program, Mitochondrial Medicine, and Pediatric Airway Disorders) have made world-changing discoveries, delivered lifesaving therapies, and provided exceptional care.